5,15-di-(4-(3,6-dibromo-9-carbazole)phenyl)-10,20-di-(4-bornyl formate phenyl)porphyrin and preparation method of 5,15-di-(4-(3,6-dibromo-9-carbazole)phenyl)-10,20-di-(4-bornyl formate phenyl)porphyrin

The invention provides 5,15-di-(4-(3,6-dibromo-9-carbazole)phenyl)-10,20-di-(4-bornyl formate phenyl)porphyrin with the molecular formula of C90H72Br4N6O4. The molecular structural formula (I) is shown as in the specification. A preparation method of the 5,15-di-(4-(3,6-dibromo-9-carbazole)phenyl)-10,20-di-(4-bornyl formate phenyl)porphyrin comprises the following steps: synthesizing 9-(4-formylphenyl)carbazole by carbazole and p-fluorobenzaldehyde and brominating the 9-(4-formylphenyl)carbazole by Br2 to obtain 3,6-dibromo-9-(4-formylphenyl)carbazole; synthesizing 5-(4-(3,6-dibromo-9-carbazole)phenyl)dipyrromethane by taking the 3,6-dibromo-9-(4-formylphenyl)carbazole and pyrrole as raw materials under the catalytic effect of trifluoroacetic acid; finally, taking the 5-(4-(3,6-dibromo-9-carbazole)phenyl)dipyrromethane and p-bornyl formate benzaldehyde to react to prepare the 5,15-di-(4-(3,6-dibromo-9-carbazole)phenyl)-10,20-di-(4-bornyl formate phenyl)porphyrin. The compound provided by the invention has relatively good solubility in organic solvents including dichloromethane, chloroform, N,N-dimethylformamide and the like, and has a potential application prospect in the fields of biomedicine, photoelectric functional materials and the like.